GLOBUS MEDICAL, INC. Proceeds from Sale of Available-for-sale Securities
GLOBUS MEDICAL, INC. (GMED) reported Proceeds from Sale of Available-for-sale Securities of $58.15 million for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-04.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities · last filed 2021-08-04
- GLOBUS MEDICAL, INC. proceeds from sale of available-for-sale securities for the quarter ending 2021-06-30 was $24.34M, a 102.28% increase year-over-year.
- GLOBUS MEDICAL, INC. proceeds from sale of available-for-sale securities for the quarter ending 2021-03-31 was $33.82M, a 529.29% increase year-over-year.
- GLOBUS MEDICAL, INC. proceeds from sale of available-for-sale securities for the quarter ending 2020-12-31 was $28.95M, a 295.97% increase year-over-year.
- GLOBUS MEDICAL, INC. proceeds from sale of available-for-sale securities for the quarter ending 2020-09-30 was $22.54M, a 7.41% increase year-over-year.
- GLOBUS MEDICAL, INC. proceeds from sale of available-for-sale securities for fiscal 2020 was $68.90M, a 28.09% increase from fiscal 2019.
- GLOBUS MEDICAL, INC. proceeds from sale of available-for-sale securities for fiscal 2019 was $53.79M, a 49.44% decline from fiscal 2018.
- GLOBUS MEDICAL, INC. proceeds from sale of available-for-sale securities for fiscal 2018 was $106.39M, a 13.16% decline from fiscal 2017.
- GLOBUS MEDICAL, INC. proceeds from sale of available-for-sale securities for fiscal 2017 was $122.51M, a 132.02% increase from fiscal 2016.
| Period end | Proceeds from Sale of Available-for-sale Securities 3 month | Proceeds from Sale of Available-for-sale Securities 3 month as first filed | Proceeds from Sale of Available-for-sale Securities 6 month | Proceeds from Sale of Available-for-sale Securities 6 month as first filed | Proceeds from Sale of Available-for-sale Securities 9 month | Proceeds from Sale of Available-for-sale Securities 9 month as first filed | Proceeds from Sale of Available-for-sale Securities 12 month |
|---|---|---|---|---|---|---|---|
| 2021-06-30 | $24.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $58.15M 10-Q · filed 2021-08-04 | $87.11M derived: sum of 3 quarters · filed 2021-08-04 | $109.65M derived: sum of 4 quarters · filed 2021-08-04 | |||
| 2021-03-31 | $33.82M 10-Q · filed 2021-05-04 | $62.77M derived: sum of 2 quarters · filed 2021-05-04 | $85.31M derived: sum of 3 quarters · filed 2021-05-04 | $97.34M derived: sum of 4 quarters · filed 2021-08-04 | |||
| 2020-12-31 | $28.95M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $51.49M derived: sum of 2 quarters · filed 2021-02-17 | $63.52M derived: sum of 3 quarters · filed 2021-08-04 | $68.90M 10-K · filed 2021-02-17 | |||
| 2020-09-30 | $22.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | $34.57M derived: sum of 2 quarters · filed 2021-08-04 | $39.94M 10-Q · filed 2020-10-28 | $47.26M derived: sum of 4 quarters · filed 2021-08-04 | |||
| 2020-06-30 | $12.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $17.41M 10-Q · filed 2021-08-04 | $24.72M derived: sum of 3 quarters · filed 2021-08-04 | $45.70M derived: sum of 4 quarters · filed 2021-08-04 | |||
| 2020-03-31 | $5.37M 10-Q · filed 2021-05-04 | $12.69M derived: sum of 2 quarters · filed 2021-05-04 | $33.67M derived: sum of 3 quarters · filed 2021-05-04 | $47.39M derived: sum of 4 quarters · filed 2021-05-04 | |||
| 2019-12-31 | $7.31M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $28.30M derived: sum of 2 quarters · filed 2021-02-17 | $42.01M derived: sum of 3 quarters · filed 2021-02-17 | $53.79M 10-K · filed 2021-02-17 | |||
| 2019-09-30 | $20.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | $34.70M derived: sum of 2 quarters · filed 2020-10-28 | $46.47M 10-Q · filed 2020-10-28 | $46.47M derived: sum of 4 quarters · filed 2021-02-17 | |||
| 2019-06-30 | $13.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $25.49M 10-Q · filed 2020-08-05 | $25.49M derived: sum of 3 quarters · filed 2021-02-17 | $68.14M derived: sum of 4 quarters · filed 2021-02-17 | |||
| 2019-03-31 | $11.77M 10-Q · filed 2020-05-07 | $11.77M derived: sum of 2 quarters · filed 2021-02-17 | $54.42M derived: sum of 3 quarters · filed 2021-02-17 | $116.83M derived: sum of 4 quarters · filed 2021-02-17 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-K 9 month · filed 2021-02-17 | $42.65M derived: sum of 2 quarters · filed 2021-02-17 | $105.06M derived: sum of 3 quarters · filed 2021-02-17 | $106.39M 10-K · filed 2021-02-17 | |||
| 2018-09-30 | $42.65M derived: 10-K 9 month − 10-Q 6 month · filed 2020-02-20 | $105.06M derived: sum of 2 quarters · filed 2020-02-20 | $106.39M 10-K · filed 2020-02-20 | $85.23M 10-Q · filed 2018-11-08 | $194.15M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-06-30 | $62.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $63.74M 10-Q · filed 2019-08-01 | $151.50M derived: sum of 3 quarters · filed 2020-03-02 | $153.56M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-03-31 | $1.33M 10-Q · filed 2019-05-02 | $89.09M derived: sum of 2 quarters · filed 2020-03-02 | $91.16M derived: sum of 3 quarters · filed 2020-03-02 | $108.34M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2017-12-31 | $87.76M derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-02 | $89.82M derived: sum of 2 quarters · filed 2020-03-02 | $107.01M derived: sum of 3 quarters · filed 2020-03-02 | $122.51M 10-K/A · filed 2020-03-02 | |||
| 2017-09-30 | $2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $19.25M derived: sum of 2 quarters · filed 2018-11-08 | $34.75M 10-Q · filed 2018-11-08 | $11.57M 10-Q · filed 2017-11-09 | $40.44M derived: sum of 4 quarters · filed 2019-02-21 | ||
| 2017-06-30 | $17.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $32.69M 10-Q · filed 2018-08-02 | $9.50M 10-Q · filed 2017-08-03 | $38.38M derived: sum of 3 quarters · filed 2019-02-21 | $68.89M derived: sum of 4 quarters · filed 2019-02-21 | ||
| 2017-03-31 | $15.51M 10-Q · filed 2018-05-03 | $6.50M 10-Q · filed 2017-05-04 | $21.20M derived: sum of 2 quarters · filed 2019-02-21 | $51.70M derived: sum of 3 quarters · filed 2019-02-21 | $60.51M derived: sum of 4 quarters · filed 2019-02-21 | ||
| 2016-12-31 | $5.69M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $36.20M derived: sum of 2 quarters · filed 2019-02-21 | $45.00M derived: sum of 3 quarters · filed 2019-02-21 | $52.80M 10-K · filed 2019-02-21 | |||
| 2016-09-30 | $30.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $39.31M derived: sum of 2 quarters · filed 2017-11-09 | $47.11M 10-Q · filed 2017-11-09 | $58.77M derived: sum of 4 quarters · filed 2018-02-22 | |||
| 2016-06-30 | $8.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $16.60M 10-Q · filed 2017-08-03 | $28.27M derived: sum of 3 quarters · filed 2018-02-22 | $35.24M derived: sum of 4 quarters · filed 2018-02-22 | |||
| 2016-03-31 | $7.80M 10-Q · filed 2017-05-04 | $19.46M derived: sum of 2 quarters · filed 2018-02-22 | $26.44M derived: sum of 3 quarters · filed 2018-02-22 | $45.76M derived: sum of 4 quarters · filed 2018-02-22 | |||
| 2015-12-31 | $11.66M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $18.64M derived: sum of 2 quarters · filed 2018-02-22 | $37.96M derived: sum of 3 quarters · filed 2018-02-22 | $57.73M 10-K · filed 2018-02-22 | |||
| 2015-09-30 | $6.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $26.30M derived: sum of 2 quarters · filed 2016-11-09 | $46.06M 10-Q · filed 2016-11-09 | $49.77M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-06-30 | $19.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-27 | $39.09M 10-Q · filed 2016-07-27 | $42.79M derived: sum of 3 quarters · filed 2017-03-16 | $49.67M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-03-31 | $19.76M 10-Q · filed 2016-05-04 | $23.47M derived: sum of 2 quarters · filed 2017-03-16 | $30.35M derived: sum of 3 quarters · filed 2017-03-16 | $33.22M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | $3.71M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $10.58M derived: sum of 2 quarters · filed 2017-03-16 | $13.46M derived: sum of 3 quarters · filed 2017-03-16 | $27.74M 10-K · filed 2017-03-16 | |||
| 2014-09-30 | $6.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $9.75M derived: sum of 2 quarters · filed 2015-11-04 | $24.03M 10-Q · filed 2015-11-04 | $32.69M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $2.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $17.16M 10-Q · filed 2015-07-31 | $25.81M derived: sum of 3 quarters · filed 2016-02-29 | $30.79M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | $14.28M 10-Q · filed 2015-05-05 | $22.94M derived: sum of 2 quarters · filed 2016-02-29 | $27.92M derived: sum of 3 quarters · filed 2016-02-29 | $27.92M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $8.66M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $13.64M derived: sum of 2 quarters · filed 2016-02-29 | $13.64M derived: sum of 3 quarters · filed 2016-02-29 | $13.64M 10-K · filed 2016-02-29 | |||
| 2013-09-30 | $4.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $4.98M derived: sum of 2 quarters · filed 2014-10-31 | $4.98M 10-Q · filed 2014-10-31 | $4.98M derived: sum of 4 quarters · filed 2015-02-26 | |||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $0.00 10-Q · filed 2014-08-06 | $0.00 derived: sum of 3 quarters · filed 2015-02-26 | ||||
| 2013-03-31 | $0.00 10-Q · filed 2014-04-30 | $0.00 derived: sum of 2 quarters · filed 2015-02-26 | |||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $0.00 10-K · filed 2015-02-26 | |||||
| 2012-09-30 | $0.00 10-Q · filed 2013-10-31 | ||||||
| 2011-12-31 | $0.00 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |